G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,717,000 | -11.9% | 137,472 | -46.4% | 0.02% | +50.0% |
| Q1 2022 | $1,949,000 | -44.9% | 256,500 | -25.9% | 0.01% | -36.8% |
| Q4 2021 | $3,534,000 | +25.5% | 346,124 | +64.9% | 0.02% | 0.0% |
| Q3 2021 | $2,816,000 | +6.4% | 209,836 | +73.9% | 0.02% | +11.8% |
| Q2 2021 | $2,647,000 | -22.9% | 120,655 | -15.4% | 0.02% | -26.1% |
| Q1 2021 | $3,433,000 | +564.0% | 142,697 | +396.3% | 0.02% | +360.0% |
| Q4 2020 | $517,000 | -34.7% | 28,751 | -58.1% | 0.01% | -50.0% |
| Q3 2020 | $792,000 | +174.0% | 68,581 | +476.0% | 0.01% | +150.0% |
| Q2 2020 | $289,000 | -71.0% | 11,906 | -68.4% | 0.00% | -73.3% |
| Q4 2019 | $995,000 | -11.2% | 37,648 | -23.5% | 0.02% | -16.7% |
| Q3 2019 | $1,121,000 | -36.4% | 49,205 | -14.4% | 0.02% | -41.9% |
| Q2 2019 | $1,763,000 | +90.6% | 57,501 | +3.2% | 0.03% | +106.7% |
| Q1 2019 | $925,000 | – | 55,719 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |